http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#Head
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#provenance
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#pubinfo
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion
http://purl.obolibrary.org/obo/DOID_9253
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9253
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB08896
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
http://www.w3.org/2000/01/rdf-schema#label
stivarga is a kinase inhibitor indicated for the treatment of patients with 1 1 1 2 stivarga is indicated for the treatment of patients with metastatic colorectal cancer crc who have been previously treated with fluoropyrimidine oxaliplatin and irinotecan based chemotherapy an anti vegf therapy and if ras wild type an anti egfr therapy stivarga is indicated for the treatment of patients with locally advanced unresectable or metastatic gastrointestinal stromal tumor gist who have been previously treated with imatinib mesylate and sunitinib malate stivarga is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB08896
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#provenance
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#pubinfo
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig
http://purl.org/nanopub/x/hasSignature
e8IYKCAPFzSbZkByn9TqSSmsX3mC+eLS1JbPT5wchH9wl6AnqmFlOpbUoicMm1uo4RHbfy9eqVCEuC9VPANAsLlOWE83UsdtTOWuoGeE+/jw4CTuDxkq12p/I7k8havuMWI4QEmE9UBp+811LTFTHZ0tIjFl8U2DSJk9uK2BOWA=
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://purl.org/dc/terms/created
2021-06-12T14:55:59.525+02:00
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs